ClinConnect ClinConnect Logo
Search / Trial NCT06620549

Feasibility of Nurse-performed Gastric Ultrasound After Surgery

Launched by RADBOUD UNIVERSITY MEDICAL CENTER · Sep 26, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at whether nurses can effectively use a special type of ultrasound, called gastric ultrasound, to check how well the stomach is emptying after major abdominal surgery. After such surgeries, some patients may have difficulty tolerating food due to changes in how their stomach works. The study will assess if trained nurses can perform this ultrasound safely and accurately in patients who have recently undergone gastrointestinal surgery.

To participate in this trial, you need to be an adult over 18 years old and have had certain types of gastrointestinal surgeries, like liver or colorectal surgery. Participants should be admitted to the hospital for at least three days and must provide written consent to join. However, if you have an open abdominal wound or certain types of feeding tubes, you won't be eligible. If you decide to take part, you'll help researchers understand how nurse-performed gastric ultrasound can be used in clinical settings, which could improve care for future patients after similar surgeries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients (\>18 years)
  • * Underwent gastrointestinal surgery:
  • partial liver resection,
  • colorectal resection,
  • HIPEC,
  • pancreatic procedures including Whipple procedures for pancreatic cancer or pancreatic disorders,
  • other gastro- intestinal abdominal procedures such as resections of sarcomas, correction of herniation.
  • Obtained written informed consent.
  • Admitted for at least 3 days.
  • Exclusion Criteria:
  • patients with open abdominal wounds or with abdominal pain hindering adequate gastric ultrasound
  • patients with a Percutaneous Endoscopic Gastrostomy catheter

About Radboud University Medical Center

Radboud University Medical Center is a leading academic medical institution located in Nijmegen, the Netherlands, dedicated to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, Radboud UMC leverages its multidisciplinary expertise to conduct high-quality research that aims to improve patient outcomes and enhance medical knowledge. The center is committed to ethical standards and regulatory compliance, fostering collaboration among researchers, healthcare professionals, and patients to translate scientific discoveries into effective clinical applications. With a focus on personalized medicine and cutting-edge technologies, Radboud University Medical Center plays a pivotal role in shaping the future of healthcare through its rigorous clinical trial initiatives.

Locations

Nijmegen, Gelderland, Netherlands

Patients applied

0 patients applied

Trial Officials

Harm HJ van Noort, PhD

Principal Investigator

Radboud University Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported